Stay updated on Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.6.4 has been added to the page, replacing the previous revision label. The removal of Revision: v3.6.3 reflects a CMS/page version update and does not change the study details.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates a minor platform revision rather than any changes to trial details.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer build of the page rendering. This appears to reflect behind-the-scenes updates rather than changes to the study information.SummaryDifference0.1%

- Check57 days agoChange DetectedNew user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the recruitment status now reads 'No longer looking for participants'. The Intervention/Treatment heading punctuation was standardized, and the revision version updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check64 days agoChange Detected- Revision: v3.5.5 replaces the previous Revision: v3.5.4 in the page's revision history, indicating the latest build of the page.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision entry, v3.5.4, was added to the revision history, replacing the previous v3.5.3; this reflects an update to the page's documentation/metadata.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.